Nanoparticles as carriers of proteins, peptides and other therapeutic molecules

被引:61
|
作者
Pudlarz, Agnieszka [1 ]
Szemraj, Janusz [1 ]
机构
[1] Med Univ Lodz, Dept Med Biochem, Lodz, Poland
来源
OPEN LIFE SCIENCES | 2018年 / 13卷 / 01期
关键词
Nanoparticles; carriers; drug delivery systems; active transport; protein carriers; WALLED CARBON NANOTUBES; DRUG-DELIVERY SYSTEM; SILVER NANOPARTICLES; GOLD NANOPARTICLES; MAGNETIC NANOPARTICLES; IN-VITRO; ANTICANCER ACTIVITY; TOPICAL DELIVERY; CANCER CELLS; LIPOSOMES;
D O I
10.1515/biol-2018-0035
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Nanoparticles have many applications both in industry and medicine. Depending upon their physical and chemical properties, they can be used as carriers of therapeutic molecules or as therapeutics. Nanoparticles are made of synthetic or natural polymers, lipids or metals. Their use allows for faster transport to the place of action, thus prolonging its presence in the body and limiting side effects. In addition, the use of such a drug delivery system protects the drug from rapid disintegration and elimination from the body. In recent years, the use of proteins and peptides as therapeutic molecules has grown significantly. Unfortunately, proteins are subject to enzymatic digestion and can cause unwanted immune response beyond therapeutic action. The use of drug carriers can minimize undesirable side effects and reduce the dose of medication needed to achieve the therapeutic effect. The current study presents the use of several selected drug delivery systems for the delivery of proteins, peptides and other therapeutic molecules.
引用
收藏
页码:285 / 298
页数:14
相关论文
共 50 条
  • [1] Nanoparticles to stabilize and release therapeutic proteins and peptides
    Maynard, Heather
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [2] Lipid based multivesicular carriers for sustained delivery of therapeutic proteins and peptides
    Katre, NV
    BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 2001, : 8 - +
  • [3] Drug Carriers for the Delivery of Therapeutic Peptides
    Du, Alice W.
    Stenzel, Martina H.
    BIOMACROMOLECULES, 2014, 15 (04) : 1097 - 1114
  • [4] Improvements in chemical carriers of proteins and peptides
    Bolhassani, Azam
    CELL BIOLOGY INTERNATIONAL, 2019, 43 (04) : 437 - 452
  • [5] Automated Design of Macrocycles for Therapeutic Applications: From Small Molecules to Peptides and Proteins
    Sindhikara, Dan
    Wagner, Michael
    Gkeka, Paraskevi
    Guessregen, Stefan
    Tiwari, Garima
    Hessler, Gerhard
    Yapici, Engin
    Li, Ziyu
    Evers, Andreas
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (20) : 12100 - 12115
  • [6] Therapeutic Proteins and Peptides PREFACE
    Donev, Rossen
    THERAPEUTIC PROTEINS AND PEPTIDES, 2018, 112 : XIII - XIV
  • [7] Hybrid Organomineral Carriers for Therapeutic Proteins
    Zelenikhin, P. V.
    Galeeva, A. G.
    Islamova, R. R.
    Lopatin, O. N.
    Yarullin, R. S.
    Ilinskaya, O. N.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2023, 49 (02) : 298 - 305
  • [8] Hybrid Organomineral Carriers for Therapeutic Proteins
    P. V. Zelenikhin
    A. G. Galeeva
    R. R. Islamova
    O. N. Lopatin
    R. S. Yarullin
    O. N. Ilinskaya
    Russian Journal of Bioorganic Chemistry, 2023, 49 : 298 - 305
  • [9] Cell penetrating peptides: Efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules
    Farkhani, Samad Mussa
    Valizadeh, Alireza
    Karami, Hadi
    Mohammadi, Samane
    Sohrabi, Nasrin
    Badrzadeh, Fariba
    PEPTIDES, 2014, 57 : 78 - 94
  • [10] Therapeutic peptides targeting intracellular molecules
    Zaman, Rahela
    Chowdhury, Ezharul Hoque
    EUROPEAN POLYMER JOURNAL, 2024, 219